Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/2/04 18:28 | 4/14/04 | ICPHC | Health | Drug | Pharmaceutical Preparations | Fleming Jonathan | MA | DT | P.adm | 14,909 | 0.4000 | 0 | 37,273 | 575 | 43,755 | I | |||||||||||||||
7/2/04 18:27 | 4/14/04 | ICPHC | Health | Drug | Pharmaceutical Preparations | Oxford Bioscience Partners IV LP | MA | T | P.adm | 14,767 | 0.4000 | 0 | 36,916 | 575 | 43,333 | D | |||||||||||||||
6/17/04 17:48 | 4/14/04 | ICPHC | Health | Drug | Pharmaceutical Preparations | Fleming Jonathan | MA | DT | P.dm | 14,871 | 0.7500 | 0 | 19,828 | 306 | 26,309 | I | |||||||||||||||
6/17/04 17:47 | 4/14/04 | ICPHC | Health | Drug | Pharmaceutical Preparations | Oxford Bioscience Partners IV LP | MA | T | P.dm | 14,736 | 0.7500 | 0 | 19,648 | 306 | 26,065 | D | |||||||||||||||
1/14/04 17:08 | 8/1/03 | PHGN | Health | Drug | Pharmaceutical Preparations | Xmark Asset Management LLC | NY | T | P.dm | 109 | 1.00 | 0 | 109 | 5 | 2,448 | I |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |